RxDoctor Payments Data

Avelina Vitug, MD

Psychiatry · Marion, INNPI 1417061284

Payments from drug & device makers

$670in general payments, 2019–2025

Across 33 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$320
  • Alkermes, Inc.$83
  • Otsuka America Pharmaceutical, Inc.$75
  • Sunovion Pharmaceuticals Inc.$69
  • Vanda Pharmaceuticals Inc.$68
  • Neurocrine Biosciences, Inc.$21
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$46369%
  • Education$20631%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$670 in reported general payments places this provider in the 60th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Medicare billing

Part B allowed, 2024
$15,087
Medicare patients
58
Services billed
227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate248$738,345
Invega TrinzaPaliperidone Palmitate11$94,563
Risperidone ErRisperidone Microspheres70$73,312
Abilify MaintenaAripiprazole21$55,233
Paliperidone ErPaliperidone170$54,096
Risperdal ConstaRisperidone Microspheres42$53,158
VraylarCariprazine Hcl26$38,925
Clozapine OdtClozapine46$25,342
FetzimaLevomilnacipran Hcl41$18,710
RexultiBrexpiprazole13$17,427
Olanzapine297$17,012
Lurasidone Hcl135$15,528
TrintellixVortioxetine Hydrobromide25$11,814
Hydroxyzine Hcl457$9,505
Divalproex Sodium ErDivalproex Sodium122$8,295

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta, Invega$16$890,699314 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$75$72,66034 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 514 psychiatry providers in Indiana.

Other psychiatry in Marion

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →